Belgium’s food safety agency AFSCA-FAVV has ordered Ferrero to suspend production at its plant in Arlon, Belgium due to a link that has been confirmed between more than a hundred cases of salmonella and Kinder chocolate production.
According to AFSCA-FAVV, the decision to temporarily close the plant was taken after finding the information from Ferrero to be incomplete.
Ferrero, the Italian chocolate giant, canceled a number of its Kinder products last week owing to salmonella concerns.
The tainted chocolate was made at Ferrero's Arlon plant, where salmonella was discovered in a filter in December.
According to the Food Standards Agency in the United Kingdom, at least 63 instances of salmonella have been connected to Kinder products, with the majority of the cases occurring in children under the age of five.
Other countries affected by recalls included the US and several European states.
Ferrero acknowledged internal inefficiencies that caused delays in retrieving and sharing information promptly.
Ferrero revealed that the plant would only reopen once certified by the authorities.


Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
3 clinical-grade skincare creams you really shouldn’t buy online
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
US Judge Dismisses Gautam Adani Criminal Charges
JPMorgan Plans More Asia-Pacific Hiring in 2027 as Corporate Banking Revenue Surges
OpenAI Restricts Astra AI Over Cyberattack Risks
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
South Korean Won Leads Asian FX Losses as Dollar Rises
Singapore Raises 2026 GDP Growth Forecast to 4.5%-5.5% as AI Boom Fuels Economy
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
Yen Stabilizes After Intervention Slide as Australian Dollar Hits Eight-Week High
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 



